A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells is a research paper published in Molecular Therapy — Nucleic Acids (2022). On theSindex it has a DataRank of 0.457. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Cold Spring Harbor Laboratory
University of Massachusetts Medical School
FWCI
1.49
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords